CLINICAL_TRIALS
trial_result
· 2023-03-15
Clinical Trial Update: Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH) [Phase 4]
Summary
Phase 4 trial update on the effect of vaginal estrogen for asymptomatic microhematuria; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medstar Health Research Institute | Conditions: Microscopic Hematuria | Phase 4 | Status: TERMINATED | Results posted: 2023-03-15